Bioengineered · 2021 · 17 citations · 34 references
Life SciencesNeurosciencePharmacologyNeuroimmunologyNeuropharmacologySepsisBlood-brain Barrier DysfunctionBlood-brain Barrier PharmacologyNeuroinflammationNeuroprotectionSepsis PathophysiologySepsis PharmacotherapyAnti-inflammatory MechanismsAnti-inflammatory TherapeuticsBlood-brain Barrier PermeabilityCabergoline TreatmentDopamine D2-like ReceptorsSepsis-associated Barrier DysfunctionSepsis-associated EncephalopathySepsis-associated Inflammation
Sepsis is a disease induced by severe systemic inflammation and contributes to multiple acute organic dysfunctions. It is reported that disrupted blood-brain barrier (BBB) integrity is involved in sepsis-associated encephalopathy (SAE), which can be alleviated by repairing the damaged tight junction structure. Cabergoline is a specific dopamine D2 receptor agonist developed to treat Parkinson’s disease and hyperprolactinemia and is reported to exert promising anti-inflammatory properties. The present study aimed to explore the beneficial effect of Cabergoline for the treatment of sepsis. In the animal experiments, mice were separated into 4 groups: sham, LPS (5 mg/kg), Cabergoline (0.1 mg/kg/day), and Cabergoline+LPS. We found that the increased neurological deficits, disrupted BBB integrity, elevated production of inflammatory factors, and declined expression level of zonula occludens-1 (ZO-1) were observed in lipopolysaccharide (LPS)-treated mice, all of which were significantly reversed by the administration of Cabergoline. In the in vitro model, human brain microvascular endothelial cells (HBMECs) were challenged with 1 µg/mL LPS in the presence or absence of Cabergoline (10, 20 μM) for 24 hours. The elevated cell permeability Papp value of fluorescein disodium across the HBMECs monolayer and declined trans-endothelial electrical resistance (TEER) in the LPS-treated HBMECs were significantly alleviated by Cabergoline, accompanied by the upregulation of ZO-1. In addition, wnt1 and β-catenin were found downregulated, which was reversed by Cabergoline. Importantly, the protective benefits of Cabergoline were all abolished by the overexpression of Dickkopf 3 (DKK3). Taken together, our data reveal that Cabergoline possessed a protective effect on BBB integrity against LPS.
34
R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes et al. · Critical Care Medicine · 2013 · 9.7K citations
Veterinary Medicine, Infectious Diseases, Internal Medicine +9
Wnt/β-catenin signaling controls development of the blood–brain barrier
Stefan Liebner, Monica Corada, Thorsten Bangsow et al. · The Journal of Cell Biology · 2008 · 841 citations · Full text
Sepsis definitions: time for change
Jean‐Louis Vincent, Steven M. Opal, John C. Marshall et al. · The Lancet · 2013 · 725 citations
Veterinary Medicine, Infectious Diseases, Internal Medicine +12
William A. Banks, Alicia M. Gray, Michelle A. Erickson et al. · Journal of Neuroinflammation · 2015 · 625 citations · Full text
The Neuropathology of Septic Shock
Tarek Sharshar, Djillali Annane, Geoffroy Lorin de la Gradmaison et al. · Brain Pathology · 2004 · 338 citations · Full text